In cisplatin-resistant ovarian cancer cells, tumor-intrinsic PD-L1 knockdown improves chemosensitivity, stimulates apoptosis, and arrests the cell cycle (Zuo et al., 2020[164]). The gene discussed is CD274; the disease is ovarian cancer.